# MEMORANDUM

**To:** General Counsel, Rookwell Medical Systems
**Re:** Sereva Diagnostics' petition to recognize the Varen Commercial Court judgment ($7.6M)
**Bottom line:** The $6.4 million compensatory award will be recognized. The $1.2 million "market-integrity surcharge" is not recognizable and must be severed under § 8. Every other defense Rookwell has raised fails, and pressing them would be affirmatively harmful. Recommended course: concede recognition of $6.4M, defeat the surcharge, and buy orderly repayment terms with negotiated security rather than uncontrolled execution against $9M of operating assets.

---

## 1. Finality, conclusiveness, enforceability (§ 1) — Sereva wins

Sereva bears this burden (§ 9) and carries it easily with (a) a certified copy of the March 1 written judgment, (b) the appellate order dismissing the appeal as untimely, and (c) a Varen-law declaration that the judgment is enforceable.

The late appeal is not merely unhelpful — § 1 expressly forecloses the argument: "A judgment may be final even though an untimely appeal was attempted." Rookwell filed on day 31 under a 20-day rule; the dismissal *confirms* finality by exhausting appellate review. Nothing is pending in Varen, and the judgment is conclusive there on the claims litigated. Do not contest this element.

## 2. Personal jurisdiction (§§ 3–4) — three independent conclusive bases

Section 4 makes jurisdiction *conclusively* sufficient on any one of three grounds. Rookwell satisfies all three:

1. **Written forum agreement.** The distribution agreement designates the Commercial Court of Varen as the *exclusive* forum. That is a written agreement to the foreign forum.
2. **Business office there concerning the dispute.** A six-person Varen sales office with a registered agent, and the dispute is about diverted *hospital orders* and minimum purchases — precisely that office's business.
3. **Appearance on the merits without limitation.** Rookwell answered, asserted **two counterclaims**, took discovery, and litigated ten months. Counterclaims are the strongest form of submission: Rookwell affirmatively invoked the court's power to grant it relief. There was no jurisdictional limitation of the appearance.

Note also that § 5's "violated a valid agreement to resolve the dispute elsewhere" ground runs *against* Rookwell: the clause pointed to Varen, so Sereva's filing honored it. Attacking the clause is self-defeating and would also undermine any thought of suing Sereva in State Alder.

## 3. Notice, including after counsel withdrew (§ 3) — sufficient

Initial service: personal delivery to the Varen registered agent plus email to the general-counsel inbox on February 5, two days after filing. That is notice "reasonably calculated to permit a defense in sufficient time" by any measure.

Post-withdrawal: the withdrawal order and trial date went to three channels (registered agent, GC inbox, deputy GC). The deputy general counsel **actually opened it on December 16**, thirty days before the January 15 trial, and the court had allowed 30 days to substitute counsel. The rule requires reasonable notice and time, not a favorable outcome.

The deputy GC's memo — "Let Sereva get whatever paper it gets and we will fight enforcement at home" — is fatal to any notice or fair-opportunity theory: it establishes actual knowledge and a *deliberate*, strategic default. **Practical warning:** if Rookwell puts its knowledge, diligence, or state of mind at issue by contesting notice, it invites discovery into that memo and risks a privilege waiver plus a judicial finding of bad faith that will color every other ruling (including any stay and any fee award). Do not contest notice.

Section 7 independently disposes of the point: a default or uncontested trial "is not, by itself, a refusal ground when the defendant had notice and a fair opportunity to participate." Rookwell's inability or refusal to pay its own Varen counsel is not a due-process deprivation; there is no right to a subsidized defense abroad.

## 4. System-wide due process (§ 2) — fails, and is close to frivolous

Section 2 asks whether the judicial *system as a whole* lacks impartial tribunals or fundamental-due-process-compatible procedures. It is a systemic, not case-specific, inquiry, and courts apply it to systems in collapse — not to systems that differ from ours in judicial-selection method.

Rookwell's two data points do not come close:

- **Ministry appointment of commercial judges.** Executive appointment is common worldwide, including in systems universally recognized. Without evidence of removal-at-will, salary manipulation, case assignment control, or actual interference, appointment method proves nothing.
- **72% foreign-defendant loss rate in "reported" cases.** Aggregate outcome statistics are not evidence of partiality. There is no control for case selection (strong defenses settle; cross-border suits are often collection actions on documentary claims), no baseline domestic-defendant rate, no merits coding, and "reported cases" is a self-selecting sample. A 72% plaintiff win rate in commercial collection litigation is unremarkable.

Worse, Rookwell's own source defeats it: public hearings, evidence presentation, cross-examination, reasoned written opinions, appellate review, and private counsel freely representing foreign companies. That is a catalogue of the hallmarks § 2 protects. And this case tracks that description — Rookwell had counsel, answered, counterclaimed, took discovery, received a written judgment, and had an appeal available (which it blew).

**Evidence that would be required** (and that we do not have): expert testimony on tenure, removal, and salary protections; documented executive or ministerial direction of outcomes; credible reports of systematic bribery; nationality-based procedural disabilities; secret or unreasoned judgments; denial of foreign parties' access to counsel; corroborating governmental or NGO country reports. Rookwell concedes there is no evidence of bribery, political direction, or denial of process here.

Advancing this ground on the present record risks a frivolousness finding.

## 5. The invoice translation (§§ 5–6) — intrinsic fraud, not a defense

Section 5 permits refusal only for fraud "that deprived the defendant of an adequate opportunity to present its case," and § 6 excludes "intrinsic fraud, disputed evidence, ordinary procedural error, or an asserted mistake of foreign law."

An omitted handwritten notation on one translated invoice is textbook intrinsic fraud: it concerns the accuracy of evidence presented *at* the trial. Decisive facts:

- Rookwell **possessed the original invoice during discovery**;
- its Varen counsel **identified the translation issue** in a trial outline;
- no objection was made; and
- Rookwell then chose not to appear to make one.

Rookwell therefore had a full opportunity to expose the discrepancy through the ordinary trial process and forfeited it. Extrinsic fraud means conduct that keeps the defendant *out* of court — concealing the suit, faking service, bribing the judge, preventing a witness from appearing. Nothing like that occurred. One invoice among "witnesses and documents" is also unlikely to be material to a $6.4M award.

Public policy (§ 5) adds nothing: an award for unpaid purchases and diverted-order losses is a garden-variety commercial claim, not repugnant to State Alder policy. There is no conflicting judgment.

## 6. No merits review (§§ 6–7)

Rookwell cannot use the recognition proceeding to retry the case. Section 7 removes the uncontested-trial complaint; § 6 removes disputed evidence, procedural error, and "asserted mistake of foreign law." The State Alder court will not reweigh Sereva's proof, reassess damages calculation, or second-guess Varen contract law. Any brief that reads as a merits appeal will be rejected and will damage credibility on the one issue we can win.

**One item to investigate:** the fate of Rookwell's two counterclaims. If they were adjudicated and rejected, they are precluded and cannot be repackaged as an offset or affirmative suit here. If the Varen record shows they were dismissed without prejudice on counsel's withdrawal, they may retain some value as leverage — but the exclusive forum clause means Rookwell would have to bring them *in Varen*, and doing so requires funding the very litigation the board refused to fund. Treat this as a settlement chip, not a litigation plan.

## 7. The $6.4M compensatory award vs. the $1.2M surcharge (§ 8) — the winnable issue

**$6.4M:** compensatory (unpaid purchases and diverted-order losses), payable to Sereva. Recognizable, and § 8 expressly *requires* recognition of the compensatory award once the nonrecognizable component is severed.

**$1.2M:** not recognizable. Every element of § 8 is met on the face of the judgment:

| § 8 element | Present here |
|---|---|
| Separately stated | Yes — a distinct line item labeled "market-integrity surcharge" |
| Penal or public-law assessment | Yes — imposed under a statute "authorizing public sanctions for deceptive distribution practices" |
| Payable to a foreign government | Yes — payable to the Varen treasury |

This is a foreign public sanction, not compensation, and Sereva is not even the payee — it has no cognizable interest in collecting money owed to its own government. The item is cleanly severable (a discrete sum on a discrete statutory basis), so severance does not disturb the $6.4M. Independent of § 8, enforcing a foreign fiscal/penal exaction would also offend public policy under § 5.

**Result: recognition of $6.4M, denial as to $1.2M — a 16% reduction, achieved on the judgment's own face with no discovery and minimal cost.**

## 8. Burdens, summarized (§ 9)

| Issue | Bearer | Assessment |
|---|---|---|
| Finality, conclusiveness, enforceability | Sereva | Met (certified judgment, dismissal order, Varen-law declaration) |
| Systemic due process (§ 2) | Rookwell | Fails badly; no evidence |
| Lack of personal jurisdiction (§ 3) | Rookwell | Fails; three conclusive § 4 bases |
| Insufficient notice (§ 3) | Rookwell | Fails; actual receipt Dec. 16, trial Jan. 15 |
| Fraud (§ 5) | Rookwell | Fails; intrinsic, and Rookwell held the original |
| Public policy / conflicting judgment / forum breach (§ 5) | Rookwell | Fails |
| Severance of surcharge (§ 8) | Practically Rookwell to raise; Sereva must show what it seeks is recognizable under §§ 1, 8 | **Wins** — proved from the judgment text plus the Varen statute |

## 9. Recommended course

**Do not oppose recognition in full.** A global opposition loses on every ground, costs money, accrues interest, exposes the deputy GC memo, invites fee-shifting or sanctions, and destroys credibility on the severance issue. It also gives Sereva reason to seek immediate, uncontrolled execution against $9M of receivables and equipment — garnishing customer receivables would damage hospital relationships far beyond the judgment amount.

**Concrete plan:**

1. **File a narrow response.** Concede finality, jurisdiction, and notice on the record. Oppose only the $1.2M surcharge under § 8 (with § 5 as an alternative), and request entry of a recognized judgment for $6.4M plus severance of the surcharge. Attach the certified judgment and the Varen sanctions statute.
2. **Use the stay sparingly (§ 10).** The surcharge issue is a genuine recognition issue, so a short stay of *execution as to that $1.2M* is available and appropriate. Do not seek a stay of the $6.4M: the court will condition it on security for the full amount plus interest, which is worse than a negotiated schedule. If any stay is sought, propose the terms yourself (escrow or letter of credit) to control the collateral.
3. **Negotiate now, before enforcement machinery starts.** Sereva has nothing to gain from the surcharge — it cannot keep the money. Trade Rookwell's waiver of all remaining defenses and appeals, and a consent recognition judgment, for (a) Sereva's abandonment of the surcharge claim, (b) an agreed installment schedule on $6.4M, (c) a stipulated interest rate, and (d) an acceleration clause.
4. **Structure security to protect operations.** Offer a perfected lien on identified equipment and a controlled lockbox/escrow of a defined receivables pool, or a bank letter of credit, in exchange for a covenant not to garnish operating customer receivables. Substituting specific collateral for open-ended execution is the single highest-value item in this negotiation.
5. **Ancillary steps.** Confirm no conflicting judgment and no other Varen proceedings; confirm the appeal is truly exhausted; assess whether the Varen treasury could pursue the surcharge separately (§ 8 blocks recognition of it in State Alder in any event); check insurance and any indemnity from the affiliate that received the diverted orders; and verify the status of the two counterclaims before waiving anything.
6. **Governance note.** The premise of the December decision — "we will fight enforcement at home" — was mistaken. Under a recognition statute like State Alder's, a defended foreign judgment is nearly automatically enforceable, and defenses must be built in the foreign forum, not saved for the enforcement court. Escalate future foreign-litigation funding decisions to the board with that analysis attached.

**Realistic outcome:** recognition of $6.4M, denial of $1.2M, and a negotiated secured payoff that keeps receivables and equipment out of a sheriff's hands. That is the best available result, and it is available cheaply if Rookwell abandons the unwinnable arguments immediately.